Geistlich Pharma AG Bahnhofstrasse 40 CH - 6110 Wolhusen
Phone: +41 41 492 55 55 Fax: +41 41 492 56 39 info@geistlich.com
The proceeds from the "Geistlich Charity Walk & Run" have reached where they are most urgently needed: the victims of war and refugees in Ukraine. The…
2021 marked the end of a challenging year that, despite all the negative omens, turned out to be a very positive one for Geistlich. The company is…
Geistlich Biomaterials Italia is adding a new regenerative product to its portfolio in the field of sports medicine. To this end, the company has…
Geistlich employees show their solidarity with the humanitarian situation in Ukraine. 283 participants laced up their running shoes on Saturday and…
6,120 clinical professionals from 92 countries are on the pulse of regenerative dentistry with "Geistlich + YOU". With offerings such as "It's YOUR…
PD Dr. med. dent. Nadja Nänni is responsible for one of the highlights of "Geistlich + YOU3": the virtual workshop. She tells us what she is most…
Do you respond to interactive lectures by renowned speakers? Do you prefer a virtual live hands-on workshop? We offer you both from one source and a…
Prof. Dr. Frauke Müller pushes the door to geriatric dentistry wide open. She introduces listeners to her fascinating and multifaceted field, which…
Let's look back: The "Geistlich Charity Walk & Run" moved the hearts of 352 employees. In September 2021, they ran and walked the race, covering a…
Since 26 May 2021, the new and stricter legislation for the market authorization of medical devices in the EU, the Medical Device Regulation (MDR),…
In the festive setting of the event organised by the Chamber of Industry and Commerce of Central Switzerland (ihz), Geistlich CEO Ralf P. Halbach and…
Geistlich Pharma has been working successfully with Meta, the medical technology division of C.G.M. S.p.A., for many years. With the acquisition of…
Geistlich Pharma obtains 510(k) clearance from the US Food and Drug Administration (FDA) for its latest product Geistlich Nexo-Gide®. It will be…
Geistlich Pharma wins the Innovation Recognition Award for the medical device Geistlich Derma-Gide®. Launched on the US market in 2019, the product…
Five questions for Friedrich Buck, who is responsible for Geistlich's "Scientific Education" with his team. He himself is a dentist with many years of…
Geistlich Pharma's Surgery business unit becomes the exclusive distribution partner for the NUsurface® meniscus implant in Switzerland and enters into…
Last weekend Geistlich once again called for the "Geistlich Charity Walk & Run". The employees came in droves: Participants around the world ran for a…
This summer, three apprentices at Geistlich successfully obtained their Swiss Federal Certificate of Competence (EFZ). We are proud and congratulate…
Having started at Geistlich from the beginning of 2021, Dr. Ralf Halbach took the helm as CEO from July. We review his first few months in the company…
As of July 1, 2021, the management of Geistlich Pharma will be newly formed. Paul Note will hand over the controls to his successor Ralf Halbach. Rolf…
Seven questions about MEFISTO, a Horizon 2020 EU project in which Geistlich is the coordinator of the overall project as well as a scientific partner.…